PhaseV, a leader in AI/ML for clinical development, today announced the launch of its AI Conductor, a centralized platform that automates the entire clinical trial journey from protocol authoring to ...
On Wednesday, the U.S. Food and Drug Administration (FDA) published three new draft guidances that aim to offer greater clarity to sponsors of cell and gene therapies (CGTs) on issues related to ...
We urge clinical operations leaders and your technology partners to consider: What issues in our last study were discovered late? Which could have been identified by end-to-end testing? Who in our ...
Investigator-initiated trials are uniquely unsuited to a patchwork of Google Drive folders, Excel worksheets, and consumer-grade software. Industry sponsors deploy full ...
Arango today announced that PSI CRO, a global clinical research organization, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC™, an AI-enabled knowledge ...
Please provide your email address to receive an email when new articles are posted on . In our journey through academia, contract research organizations, big pharma and biotech startups, we have had ...
The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results